For Sale: Knight Therapeutics Seeks Buyers For Impavido Priority Review Voucher
This article was originally published in The Pink Sheet Daily
Executive Summary
But the small Canadian specialty company says it will be patient in finding the maximum value for the asset, awarded in connection with FDA approval of its leishmaniasis treatment.